百威亚太(01876.HK)：4Q25延续调整 公司2026年定调增长优先

Core Insights - The company's 4Q25 performance aligns with expectations, showing a decline in revenue, sales volume, ASP, and EBITDA, particularly in the Chinese market [1] - The company aims for growth in 2026, adopting a proactive approach to market challenges, with potential for recovery in the on-premise channel [2] Financial Performance - 4Q25 revenue, sales volume, ASP, and EBITDA decreased by 4.2%, 0.7%, 3.5%, and 24.7% year-on-year, respectively, with the Chinese market showing declines of 11.4%, 3.9%, 7.7%, and 42.3% [1] - The EBITDA forecast for 2026 is adjusted down by 7.1% to $1.593 billion, with a new estimate for 2027 at $1.637 billion [2] Market Trends - In China, weak demand and channel adjustments continue to pressure volume and pricing, with a 3.9% decline in sales volume attributed to poor performance in key channels [1] - The Indian market continues to show strong growth, helping to offset pressures from the Chinese market [1] Strategic Outlook - The company is prioritizing growth in 2026, with expectations for stabilization as the macro environment improves and strategic adjustments are made [2] - The current stock price reflects a valuation of 6.5x and 6.2x EV/EBITDA for 2026 and 2027, respectively, with a target price of HKD 9.80 per share indicating a potential upside of 25.2% [2]